Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protect Medical Innovation Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Protect Medical Innovation Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2018 · first_quarter · Q1
Defense Authorization Bill; general representation on extraneous affairs as they arise.
General homeland security issues; general representation on extraneous affairs as they arise.
Source: Senate LDA
| NOVARTIS CORPORATION | 37 | 2002–2012 |
| ENDO PHARMACEUTICALS | 31 | 2008–2015 |
| NATIONAL STRIPPER WELL ASSOCIATION | 30 | 2009–2015 |
| CITY OF GARDENA | 27 | 2001–2012 |
| ENTERGY SERVICES, INC | 26 | 2002–2011 |
| GRAND STRAND BUSINESS ASSOCIATION | 24 | 2009–2015 |
| ASTELLAS PHARMA US | 23 | 2008–2011 |
| TOYOTA NORTH AMERICA INC | 23 | 2006–2012 |
| CITY OF FLORENCE | 22 | 2001–2010 |
| ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC | 22 | 2012–2016 |
| ELI LILLY AND COMPANY | 19 | 2005–2010 |
| PHRMA | 17 | 2006–2010 |
| MCBRIDE ORTHOPEDIC HOSPITAL | 16 | 2012–2015 |
| TRANSOCEAN OFFSHORE DEEPWATER DRILLING INC. | 16 | 2010–2013 |
| CLEAN ENERGY | 15 | 2007–2010 |
| MCBRIDE CLINIC | 13 | 2004–2008 |
| PROFESSIONAL COMPOUNDING CENTERS OF AMERICA | 12 | 2012–2015 |
| CITY OF GLENPOOL, OKLAHOMA | 11 | 2009–2011 |
| ABBOTT LABORATORIES INC. | 10 | 2001–2005 |
| NCR CORPORATION | 10 | 2002–2006 |
| EDISON ELECTRIC INSTITUTE | 9 | 2003–2007 |
| FIDELIS GOVERNMENT RELATIONS | 9 | 2006–2008 |
| EXOTIC WILDLIFE ASSOCIATION | 8 | 2010–2012 |
| WELLNESS PHARMACY | 8 | 2013–2014 |
| COMMERCIAL BANK OF TEXAS | 7 | 2009–2010 |
| LASER SHOT INC | 7 | 2004–2007 |
| LJH, LTD. | 7 | 2014 |
| MAINE COAST MEMORIAL HOSPITAL | 7 | 2005–2008 |
| MILLENIUM PHARMACEUTICALS | 7 | 2000–2005 |
| KERR-MCGEE SHARED SERVICES CO | 6 | 2003–2005 |
| ROCK & ASSOCIATES | 6 | 2013–2014 |
| VANTEM MODULAR, LLC | 6 | 2012–2013 |
| AMERICAN CHAMBER OF COMMERCE IN RUSSIA | 5 | 2007–2008 |
| SOUTHEAST COUNCIL DAIRY FARMER | 5 | 2006–2007 |
| CF INDUSTRIES INC | 4 | 2002–2004 |
| CHLORINE CHEMISTRY COUNCIL | 4 | 2003–2004 |
| DFB PHARMACEUTICALS INC | 4 | 2003–2005 |
| HOOD CANAL SAND AND GRAVEL, LLC | 4 | 2013–2014 |
| KANE COUNTY ILLINOIS | 4 | 2005–2006 |
| KNIGHTSBRIDGE BIOFUELS LLC | 4 | 2015 |
| LASER DIAGNOSTIC INSTRUMENTS INTL | 4 | 2003 |
| LOUISIANA SHERIFFS ASSN | 4 | 2002–2004 |
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (SAIC) | 4 | 2005–2006 |
| WADDELL & REED | 4 | 2002–2005 |
| WASTE MANAGEMENT INC | 4 | 2016–2017 |
| AMGEN, INC. | 3 | 2006–2007 |
| CIGNA | 3 | 2002–2004 |
| Carrix | 3 | 2006 |
| MAXOR | 3 | 2011 |
| TRONOX LLC | 3 | 2006–2007 |
| USO | 3 | 2002–2003 |
| MSC SOFTWARE CORP | 2 | 2002 |
| ORACLE | 2 | 2002 |
| UNITED GAMEFOWL BREEDERS ASSN | 2 | 2003 |
| VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES | 2 | 2002 |
| ILLINOIS CORN GROWERS ASSN | 1 | 2002 |
| MEDICAL RESEARCH FOUNDATION | 1 | 2005 |
| PREGNANCY CARE CENTER | 1 | 2008 |
Protect Medical Innovation Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Protect Medical Innovation Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Patient Access to Higher Quality Health Care Act of 2015
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians, ownership at hospitals; H.R.976 Patient Access Higher Quality Health Care Act of 2015
Patient Access to Higher Quality Health Care Act of 2015
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians, ownership at hospitals; H.R.976 Patient Access Higher Quality Health Care Act of 2015
Patient Access to Higher Quality Health Care Act of 2015
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians, ownership at hospitals; H.R.976 Patient Access Higher Quality Health Care Act of 2015
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Supporting quality of life for prostate cancer patients.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Saving Access to Compounded Medications for Special Needs Patients Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to PL 113-54, The Drug Quality and Security Act Issues related to agriculture appropriations and defense appropriations. Issues related to S. 1406 - saving access to compound medications for special needs patients act.
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Ensuring Safe Access to Prescription Medication Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to tamper resistant formulation of pharmaceutical and generic drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Ensuring Safe Access to Prescription Medication Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to tamper resistant formulation of pharmaceutical and generic drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Ensuring Safe Access to Prescription Medication Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to tamper resistant formulation of pharmaceutical drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Ensuring Safe Access to Prescription Medication Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Issues related to tamper resistant formulation of pharmaceutical drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians to hospitals; Expanding Patients' Access to Quality Care Act of 2013 H.R.2027; Cutting Costly Codes Act of 2013 H.R.1701, S.972
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians to hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S 972- Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972- Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972- Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians to hospitals; Expanding Patients' Access to Quality Care Act of 2013 H.R.2027; Cutting Costly Codes Act of 2013 H.R.1701, S.972
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians to hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S 972- Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act S. 2360, H.R. 4679; issues relating to incentive for life sciences research' Protect Medical Innovation Act of 2013 S.232, H.R.523
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act (S.2360) (H.R.4679); issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013 (S.232) (H.R.523)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health issues, including, but not limited to, coverage and reimbursement; drug imporation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486); Safeguarding America's Pharmaceuticals Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimilars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013; Able Act H.R. 647; Medicaid Generic Drug Price Fairness Act H.R.5748, S.2984
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R.486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Protect Medical Innovation Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Protect Medical Innovation Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act S. 2360, H.R. 4679; issues relating to incentive for life sciences research' Protect Medical Innovation Act of 2013 S.232, H.R.523
Protect Medical Innovation Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act (S.2360) (H.R.4679); issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013 (S.232) (H.R.523)
Medicaid Generic Drug Price Fairness Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimilars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013; Able Act H.R. 647; Medicaid Generic Drug Price Fairness Act H.R.5748, S.2984
Medical Device Access and Innovation Protection Act
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act S. 2360, H.R. 4679; issues relating to incentive for life sciences research' Protect Medical Innovation Act of 2013 S.232, H.R.523
Medical Device Access and Innovation Protection Act
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act (S.2360) (H.R.4679); issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013 (S.232) (H.R.523)
Medical Device Access and Innovation Protection Act
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act (S.2360) (H.R.4679); issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013 (S.232) (H.R.523)
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act S. 2360, H.R. 4679; issues relating to incentive for life sciences research' Protect Medical Innovation Act of 2013 S.232, H.R.523
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Ensuring Safe Access to Prescription Medication Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Ensuring Safe Access to Prescription Medication Act of 2014 S.2825
Ensuring Safe Access to Prescription Medication Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Ensuring Safe Access to Prescription Medication Act of 2014 (S.2825)
A bill to modify the definition of cotton futures contracts in the United States Cotton Futures Act.
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimilars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013; Able Act H.R. 647; Medicaid Generic Drug Price Fairness Act H.R.5748, S.2984
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Specific issue is EPA National Priorities funding. Entity is House Senate and EPA
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise.
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise.
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate. Interior Appropriations Bill for specific issues.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2018 · first_quarter · Q1
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill.
Government funding of medical research.
General health care issues pertaining to OSU-CHS; NIH.
Federal Student Loans/Aid
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage. State of Oklahoma Medicaid waiver.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2017 · fourth_quarter · 4A
General health care issues pertaining to OSU-CHS; NIH.
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill.
Federal Student Loans/Aid
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage. State of Oklahoma Medicaid waiver.
Government funding of medical research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2017 · fourth_quarter · 4A
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise.
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate. Interior Appropriations Bill for specific issues.
General homeland security issues; general representation on extraneous affairs as they arise.
Specific issue is EPA National Priorities funding. Entity is House Senate and EPA
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise.
Tax reform; charitable giving; general representation on extraneous affairs as they arise.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2017 · fourth_quarter · Q4
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill.
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage. State of Oklahoma Medicaid waiver.
General health care issues pertaining to OSU-CHS; NIH.
Government funding of medical research.
Federal Student Loans/Aid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2017 · fourth_quarter · Q4
General transportation issues; FAA; general representation on extraneous affairs as they arise.
Specific issue is EPA National Priorities funding. Entity is House Senate and EPA
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate. Interior Appropriations Bill for specific issues.
WASTE MANAGEMENT, INC. via CAPITOL HILL CONSULTING GROUP
2017 · third_quarter · 3T
Work relating to environmental issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2017 · third_quarter · Q3
General health care issues pertaining to OSU-CHS; NIH.
Federal Student Loans/Aid
Government funding of medical research.
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2017 · third_quarter · Q3
Specific issue is EPA National Priorities funding. Entity is House Senate and EPA
General homeland security issues; general representation on extraneous affairs as they arise.
Tax reform; charitable giving; general representation on extraneous affairs as they arise.
WASTE MANAGEMENT, INC. via CAPITOL HILL CONSULTING GROUP
2017 · second_quarter · Q2
Work relating to environmental issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2017 · second_quarter · Q2
General health care issues pertaining to OSU-CHS; NIH.
Government funding of medical research.
Federal Student Loans/Aid
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2017 · second_quarter · Q2
Tax reform; charitable giving; general representation on extraneous affairs as they arise.
General homeland security issues; general representation on extraneous affairs as they arise.
General transportation issues; FAA; general representation on extraneous affairs as they arise.
WASTE MANAGEMENT, INC. via CAPITOL HILL CONSULTING GROUP
2017 · first_quarter · Q1
Work relating to environmental issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2017 · first_quarter · Q1
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise.
General homeland security issues; general representation on extraneous affairs as they arise.
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2017 · first_quarter · Q1
General health care issues pertaining to OSU-CHS; NIH.
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
Government funding of medical research.
WASTE MANAGEMENT, INC. via CAPITOL HILL CONSULTING GROUP
2016 · fourth_quarter · 4A
Work relating to environmental issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2016 · fourth_quarter · Q4
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production - Geothermal Energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2016 · fourth_quarter · Q4
Government funding of medical research.
Federal Student Loans/Aid
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2016 · fourth_quarter · Q4
General homeland security issues; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2016 · third_quarter · Q3
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production - Geothermal Energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2016 · third_quarter · Q3
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill
Federal Student Loans/Aid
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2016 · third_quarter · Q3
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2016 · second_quarter · Q2
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production - Geothermal Energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2016 · second_quarter · Q2
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill
General health care issues pertaining to OSU-CHS; NIH
Government funding of medical research.
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2016 · second_quarter · Q2
General transportation issues; FAA; general representation on extraneous affairs as they arise
Tax reform; charitable giving; general representation on extraneous affairs as they arise
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2016 · first_quarter · Q1
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production - Geothermal Energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2016 · first_quarter · Q1
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
CJS Appropriations Bill, House and Senate
Federal Student Loans/Aid
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2016 · first_quarter · Q1
General homeland security issues; general representation on extraneous affairs as they arise
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate
Tax reform; charitable giving; general representation on extraneous affairs as they arise
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · 3A
General Medicare and Medicaid issues including, but not limited to, coverage reimbursement
Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Issues related to Labor-HHS funding
NORTH AMERICAN DEER FARMERS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · 1A
monitoring all agricultural issues; agriculture appropriations
monitoring all livestock and wildlife issues and rule-making regarding livestock and wildlife
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
GRAND STRAND BUSINESS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · 2A
issues pertaining to the creation of the I-73 Corridor
general appropriations issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
POPULUS FINANCIAL GROUP, INC. (FORMERLY ACE CASH EXPRESS, INC.) via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · 1A
general financial issues pertaining to the company
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN GAS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · 3A
general environment issues, climate change issues
climate change issues, energy efficiency issues
Toxic Substance Control Act (TSCA), energy efficiency issues
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · 3A
Issues related to tamper resistant formulation of pharmaceutical and generic drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2015 · fourth_quarter · Q4
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production - Geothermal Energy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2015 · fourth_quarter · Q4
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2015 · fourth_quarter · Q4
Federal Student Loans/Aid
General health care issues pertaining to OSU-CHS; NIH
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
NATIONAL STRIPPER WELL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · fourth_quarter · Q4
Environment issues relation to stripper wells, oil exports, hydraulic fracking
Marginal Well Tax issues pertaining to, but not limited to, depletion deduction, other tax matters relation to marginal wells; hydraulic fracking
Tax matters relating to marginal and stripper wells, including the depletion deduction
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production - Geothermal Energy
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
Issues related to Labor-HHS funding
Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Controlled Drug Substances Act (21 USC 13)
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
Government funding of medical research.
Federal Student Loans/Aid
General health care issues pertaining to OSU-CHS; NIH
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
General transportation issues; FAA; general representation on extraneous affairs as they arise
Tax reform; charitable giving; general representation on extraneous affairs as they arise
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
NATIONAL STRIPPER WELL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
Tax matters relating to marginal and stripper wells, including the depletion deduction
Marginal Well Tax issues pertaining to, but not limited to, depletion deduction, other tax matters relation to marginal wells; hydraulic fracking
Environment issues relation to stripper wells, oil exports, hydraulic fracking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
General issues relating to physicians, ownership at hospitals; H.R.976 Patient Access Higher Quality Health Care Act of 2015
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KNIGHTSBRIDGE BIOFUELS LLC via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
Issues related to the environment & energy legislation
Issues related to energy
Issues related to research and development
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
AMERICAN GAS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · third_quarter · Q3
general environment issues, climate change issues
Toxic Substance Control Act (TSCA), energy efficiency issues
Toxic Substance Control Act (TSCA)
KNIGHTSBRIDGE BIOFUELS LLC via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Issues related to the environment
Issues related to energy
Issues related to agriculture
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Controlled Drug Substances Act (21 USC 13)
General Medicare and Medicaid issues including, but not limited to, coverage reimbursement
Issues related to Labor-HHS funding
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Issues related to PL 113-54, The Drug Quality and Security Act Issues related to agriculture appropriations and defense appropriations. Issues related to S. 1406 - saving access to compound medications for special needs patients act.
Issues related to DOD health/pharmacy programs
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
Tax reform; charitable giving; general representation on extraneous affairs as they arise
General homeland security issues; general representation on extraneous affairs as they arise
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
General health care issues pertaining to OSU-CHS; NIH
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding' SGR
Federal Student Loans/Aid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL STRIPPER WELL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Tax matters relating to marginal and stripper wells, including the depletion deduction
Environment issues relation to stripper wells, oil exports, hydraulic fracking
Marginal Well Tax issues pertaining to, but not limited to, depletion deduction, other tax matters relation to marginal wells; hydraulic fracking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
General issues relating to physicians, ownership at hospitals; H.R.976 Patient Access Higher Quality Health Care Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Hydraulic Fracking- treatment of oil and gas wells. Oil and natural gas production
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN GAS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · second_quarter · Q2
Toxic Substance Control Act (TSCA), energy efficiency issues
general environment issues, climate change issues
climate change issues, energy efficiency issues
KNIGHTSBRIDGE BIOFUELS LLC via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
issues related to research and development
issues related to agriculture
issues related to the environment
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
issues related to DOD health/pharmacy programs
issues related to PL 113-54, The Drug Quality and Security Act issues related to agriculture appropriations
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
General issues relating to physicians, ownership at hospitals; H.R.976 Patient Access Higher Quality Health Care Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
GRAND STRAND BUSINESS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
issues pertaining to the creation of the I-73 Corridor
general appropriations issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN DEER FARMERS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
monitoring all agricultural issues; agriculture appropriations
monitoring all livestock and wildlife issues and rule-making regarding livestock and wildlife
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
General Medicare and Medicaid issues including, but not limited to, coverage reimbursement
issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
issues related to Labor-HHS funding
POPULUS FINANCIAL GROUP, INC. (FORMERLY ACE CASH EXPRESS, INC.) via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
general financial issues pertaining to the company
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN GAS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
climate change issues, energy efficiency issues
Toxic Substance Control Act (TSCA), energy efficiency issues
general environment issues, climate change issues
NATIONAL STRIPPER WELL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
tax matters relating to marginal and stripper wells, including the depletion deduction
Marginal Well Tax issues pertaining to, but not limited to, depletion deduction, other tax matters relation to marginal wells; hydraulic fracking
environment issues relation to stripper wells, oil exports, hydraulic fracking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
Hydraulic Fracking- the treatment of oil and gas wells
Hydraulic Fracking- treatment of oil and gas wells
research and development funds for new gas turbine technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
general Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding' SGR
general health care issues pertaining to OSU-CHS; NIH
Federal Student Loans/Aid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · Q1
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
general homeland security issues; general representation on extraneous affairs as they arise
general education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
KNIGHTSBRIDGE BIOFUELS LLC via CAPITOL HILL CONSULTING GROUP
2015 · first_quarter · RR
issues related to agriculture, energy and the environment
issues related to agriculture, energy and the environment
issues related to agriculture, energy and the environment
LJH, LTD. via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · 4T
water issues; US Army Corps of Engineers
water issues; US Army Corps of Engineers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 Issues related to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
Pharmaceutical Compounding and Accountability Act S.959 The Compound Clarity Act H.R.3089 The Drug Quality and Security Act H.R.3204 2015 National Defense Authorization Act Issues related to implementation of the Compounding Quality Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
Hydraulic Fracking- treatment of oil and gas wells
research and development funds for new gas turbine technology
Hydraulic Fracking- treatment of oil and gas wells
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General issues relating to physicians to hospitals; Expanding Patients' Access to Quality Care Act of 2013 H.R.2027; Cutting Costly Codes Act of 2013 H.R.1701, S.972
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimilars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013; Able Act H.R. 647; Medicaid Generic Drug Price Fairness Act H.R.5748, S.2984
Ensuring Safe Access to Prescription Medication Act of 2014 S.2825
Medical Device Tax Repeal; Stop Corporate Inversions Act S. 2360, H.R. 4679; issues relating to incentive for life sciences research' Protect Medical Innovation Act of 2013 S.232, H.R.523
NATIONAL STRIPPER WELL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
Marginal Well Tax Credit and issues pertaining to, but not limited to, expense to intangible drilling costs and other tax matters relating to marginal wells; hydraulic fracturing
Marginal Well Tax Credit and issues pertaining to, but not limited to, expense of intangible drilling costs, other tax issues, and environment issues
Marginal Well Tax Credit and issues pertaining to, but not limited to, expense of intangible drilling costs and other tax matters relating to marginal wells
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; SGR
General Healthcare issues pertaining to OSU-CHS; NIH
Federal Student Loans/Aid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
general transportation issues; FAA; general representation on extraneous affairs, as they arise
Tax Reform; Charitable Giving; general representation on extraneous affairs, as they arise
general education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
GRAND STRAND BUSINESS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
general appropriation issues
issues pertaining to the creation of the I-73 Corridor
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN DEER FARMERS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
monitoring all agricultural issues; Agriculture Appropriations
monitoring all livestock and wildlife issues and rule-making regarding livestock and wildlife
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R.486)
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
general health issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; issues relating to prescription drug abuse; Canada compliance issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN GAS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
general environment issues
tax extenders; energy taxes
Toxic Substance Control Act (TSCA)
POPULUS FINANCIAL GROUP, INC. (FORMERLY ACE CASH EXPRESS, INC.) via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
general financial issues pertaining to the company
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LJH, LTD. via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · 4A
water issues; US Army Corps of Engineers
water issues; US Army Corps of Engineers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LJH, LTD. via CAPITOL HILL CONSULTING GROUP
2014 · fourth_quarter · Q4
water issues; US Army Corps of Engineers
water issues; US Army Corps of Engineers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; issues relating to prescription drug abuse; Canada compliance issues
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement
General issues relating to physicians to hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S 972- Cutting Costly Codes Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
General Healthcare issues pertaining to OSU CHS; NIH
Federal Student Loans/Aid
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; SGR
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013
general Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Ensuring Safe Access to Prescription Medication Act of 2014 (S.2825)
NATIONAL STRIPPER WELL ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
Marginal Well Tax Credit and issues pertaining to, but not limited to, expense of intangible drilling costs and other tax matters relating to marginal wells
Marginal Well Tax Credit and issues pertaining to, but not limited to, expense to intangible drilling costs and other tax matters relating to marginal wells; hydraulic fracturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN GAS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
Toxic Substance Control Act (TSCA)
Toxic Substance Control Act (TSCA)
Tax Extenders; Energy Taxes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORBITAL ATK INC FKA: ALLIANT TECHSYSTEMS OPERATIONS LLC via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
research and development funds for new gas turbine technology
Hydraulic Fracking- treatment of oil and gas wells
Hydraulic Fracking- treatment of oil and gas wells
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
General education issues, Federal Student Loans/Aid
General agriculture issues Federal research/competitive grants
2015 Defense Authorization bill
LJH, LTD. via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
water issues; US Army Corps of Engineers
water issues; US Army Corps of Engineers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTH AMERICAN DEER FARMERS ASSOCIATION via CAPITOL HILL CONSULTING GROUP
2014 · third_quarter · Q3
monitoring all agricultural issues; Agriculture Appropriations
monitoring all livestock and wildlife issues and rule-making regarding livestock and wildlife
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise.
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General homeland security issues; general representation on extraneous affairs as they arise.
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
Tax reform; charitable giving; general representation on extraneous affairs as they arise.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise.
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise.
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate. Interior Appropriations Bill for specific issues.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Specific issue is EPA National Priorities funding. Entity is House Senate and EPA
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise.
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate. Interior Appropriations Bill for specific issues.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
General transportation issues; FAA; general representation on extraneous affairs as they arise.
Specific issue is EPA National Priorities funding. Entity is House Senate and EPA
Tax reform; charitable giving; general representation on extraneous affairs as they arise.
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate. Interior Appropriations Bill for specific issues.
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
Federal Student Loans/Aid
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General health care issues pertaining to OSU-CHS; NIH
CJS Appropriations Bill, House and Senate. Labor-HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax reform; charitable giving; general representation on extraneous affairs as they arise
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General health care issues pertaining to OSU-CHS; NIH
Government funding of medical research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General homeland security issues; general representation on extraneous affairs as they arise
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate
Tax reform; charitable giving; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; Issues related to physician shortage.
Federal Student Loans/Aid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General homeland security issues; general representation on extraneous affairs as they arise
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
Agriculture Appropriations Bill, Defense Appropriations Bill House and Senate
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General health care issues pertaining to OSU-CHS; NIH
Government funding of medical research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General transportation issues; FAA; general representation on extraneous affairs as they arise
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Controlled Drug Substances Act (21 USC 13)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Toxic Substance Control Act (TSCA)
tax extenders; energy taxes; diesel/LNG tax parity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General homeland security issues; general representation on extraneous affairs as they arise
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
Tax reform; charitable giving; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Government funding of medical research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General Medicare and Medicaid issues including, but not limited to, coverage reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding' SGR
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
General agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
General homeland security issues; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to agriculture
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to tamper resistant formulation of pharmaceutical and generic drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
climate change issues, energy efficiency issues
tax extenders; energy taxes; diesel/LNG tax parity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to research and development
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug abuse; issues related to abuse deterrent formulations; issues related to Medicaid rebates; issues related to implementation of the Affordable Care Act; HR.471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
General education issues; Federal Student Loans/Aid; general representation on extraneous affairs as they arise
General transportation issues; FAA; general representation on extraneous affairs as they arise
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tamper resistant formulation of pharmaceutical drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
tax extenders; energy taxes; diesel/LNG tax parity
Toxic Substance Control Act (TSCA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
issues related to energy
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to tamper resistant formulation of pharmaceutical drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825
Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Controlled Drug Substances Act (21 USC 13)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Toxic Substance Control Act (TSCA)
tax extenders; energy taxes; diesel/LNG tax parity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
tax reform; charitable giving; general representation on extraneous affairs as they arise
general transportation issues; FAA; general representation on extraneous affairs as they arise
general agriculture issues; federal research; competitive grants; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 Defense Authorization Bill; general representation on extraneous affairs as they arise
general agricultural issues; federal research; competitive grants; general representation on extraneous affairs as they arise
general homeland security issues; general representation on extraneous affairs as they arise
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Toxic Substance Control Act (TSCA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medical Device Tax Repeal; Stop Corporate Inversions Act (S.2360) (H.R.4679); issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013 (S.232) (H.R.523)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General homeland security issues
Tax reform and charitable giving
General transportation issues; FAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE